The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Adipokines in health and disease
Abstract
Obesity increases the risk for metabolic, cardiovascular, chronic inflammatory, and several malignant diseases and, therefore, may contribute to shortened lifespan. Adipokines are peptides that signal the functional status of adipose tissue to targets in the brain, liver, pancreas, immune system, vasculature, muscle, and other tissues. Secretion of adipokines, including leptin, adiponectin, fibroblast growth factor 21 (FGF21), retinol-binding protein 4 (RBP4), dipeptidyl peptidase 4 (DPP-4), bone morphogenetic protein (BMP)-4, BMP-7, vaspin, apelin, and progranulin, is altered in adipose tissue dysfunction and may contribute to a spectrum of obesity-associated diseases. Adipokines are promising candidates both for novel pharmacological treatment strategies and as diagnostic tools, provided that we can develop a better understanding of the function and molecular targets of the more recently discovered adipokines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This finding that adiponectin levels are proportional to metabolic fitness has prompted the use of recombinant adiponectin and other adiponectin receptor agonists in several mouse models of obesity.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [12]
In the citing paper
“Alternatively, mouse models of obesity and unhealthy obese individuals exhibit lower circulating levels of adiponectin.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [12]
In the citing paper
“So far, the activation of adiponectin signaling has improved glucose tolerance, insulin sensitivity, and longevity in mice 12, 130.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [12]
In the citing paper
“In conditions of insulin resistance, WAT secretome is substantially altered and includes a broad range of proinflammatory factors, such as TNF‐α, IL‐6, interleukin 8 (IL‐8), and interleukin 1β (IL‐1B) and monocyte chemotactic protein 1 (MCP1) 12.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [12]
In the citing paper
“The secretion of these proinflammatory cytokines and chemokines, as well as the secretion of other adipokines like retinol binding protein 4 (RBP4) 141, 142, is now well admitted to contribute to the onset of the physiological alterations accompanying obesity 12.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [12]
In the citing paper
“However, the use of leptin analogs in combination with other agents, namely amylin, has given more encouraging results, but was stopped due to adverse secondary effects 12.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [12]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,081
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., et al. (2012) · Genes & Development · doi:10.1101/gad.177857.111 · Cited by 1,478
Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., Lubina, J. A., Patane, J., Self, B., Hunt, P., et al. (1999) · JAMA · doi:10.1001/jama.282.16.1568 · Cited by 1,422
Relationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure
Tseng, Y.-H., Kokkotou, E., Schulz, T. J., Huang, T. L., Winnay, J. N., Taniguchi, C. M., Tran, T. T., Suzuki, R., Espinoza, D. O., Yamamoto, Y., et al. (2008) · Nature · doi:10.1038/nature07221 · Cited by 1,099
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., Desimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
Apelin, a Newly Identified Adipokine Up-Regulated by Insulin and Obesity
Boucher, J., Masri, B., Daviaud, D., Gesta, S., Guigné, C., Mazzucotelli, A., Castan-Laurell, I., Tack, I., Knibiehler, B., Carpéné, C., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1427 · Cited by 910
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
Klöting, N., Fasshauer, M., Dietrich, A., Kovacs, P., Schön, M. R., Kern, M., Stumvoll, M., & Blüher, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2009 · Cited by 856
Self-citationCawthorn, W. P., & Sethi, J. K. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.051 · Cited by 833
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757
Hida, K., Wada, J., Eguchi, J., Zhang, H., Baba, M., Seida, A., Hashimoto, I., Okada, T., Yasuhara, A., Nakatsuka, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504703102 · Cited by 725
Adiponectin: mechanistic insights and clinical implications
Turer, A. T., & Scherer, P. E. (2012) · Diabetologia · doi:10.1007/s00125-012-2598-x · Cited by 650
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 641
Adipose tissue as a source of hormones
Siiteri, P. K. (1987) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/45.1.277 · Cited by 600
Leptin in Human Physiology and Pathophysiology
Mantzoros, C. S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T. A., Kim, S.-Y., Hamnvik, O.-P. R., & Koniaris, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00315.2011 · Cited by 593
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Lamers, D., Famulla, S., Wronkowitz, N., Hartwig, S., Lehr, S., Ouwens, D. M., Eckardt, K., Kaufman, J., Rydén, M., Müller, S., et al. (2011) · Diabetes · doi:10.2337/db10-1707 · Cited by 583
Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice
Dray, C., Knauf, C., Daviaud, D., Waget, A., Boucher, J., Buléon, M., Cani, P. D., Attané, C., Guigné, C., Carpéné, C., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.003 · Cited by 522
Adipocyte dysfunction, inflammation and metabolic syndrome
Klöting, N., & Blüher, M. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9301-0 · Cited by 487
Self-citationRegulation of adipocyte lipolysis
Frühbeck, G., Méndez-Giménez, L., Fernández‐Formoso, J. A., Fernández, S., & Rodrı́guez, A. (2014) · Nutrition Research Reviews · doi:10.1017/s095442241400002x · Cited by 447
Roth, J. D., Roland, B. L., Cole, R. L., Trevaskis, J. L., Weyer, C., Koda, J. E., Anderson, C. M., Parkes, D. G., & Baron, A. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706473105 · Cited by 436
Adipose tissue dysfunction contributes to obesity related metabolic diseases
Blüher, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.02.005 · Cited by 430
Self-citationAdipsin: A Circulating Serine Protease Homolog Secreted by Adipose Tissue and Sciatic Nerve
Cook, K. S., Min, H. Y., Johnson, D., Chaplinsky, R. J., Flier, J. S., Hunt, C. R., & Spiegelman, B. M. (1987) · Science · doi:10.1126/science.3299705 · Cited by 427
Wei, W., Dutchak, P. A., Wang, X., Ding, X., Wang, X., Bookout, A. L., Goetz, R., Mohammadi, M., Gerard, R. D., Dechow, P. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200797109 · Cited by 426
The starvation hormone, fibroblast growth factor-21, extends lifespan in mice
Zhang, Y., Xie, Y., Berglund, E. D., Coate, K. C., He, T. T., Katafuchi, T., Xiao, G., Potthoff, M. J., Wei, W., Wan, Y., et al. (2012) · eLife · doi:10.7554/elife.00065 · Cited by 420
Serum Vaspin Concentrations in Human Obesity and Type 2 Diabetes
Youn, B., Klöting, N., Kratzsch, J., Lee, N., Park, J. W., Song, E.-S., Ruschke, K., Oberbach, A., Faßhauer, M., Stümvoll, M., et al. (2007) · Diabetes · doi:10.2337/db07-1045 · Cited by 419
Self-citationBlüher, M., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.016 · Cited by 415
Self-citationKlöting, N., Graham, T. E., Berndt, J., Kralisch, S., Kovacs, P. L., Wason, C. J., Faßhauer, M., Schön, M. R., Stümvoll, M., Blüher, M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.002 · Cited by 405
Self-citationAdipsin Is an Adipokine that Improves β Cell Function in Diabetes
Lo, J. C., Ljubicic, S., Leibiger, B., Kern, M., Leibiger, I. B., Moede, T., Kelly, M. E., Bhowmick, D. C., Murano, I., Cohen, P., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.005 · Cited by 390
Self-citationBrown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat
Schulz, T. J., Huang, P. C., Huang, T. L., Xue, R., McDougall, L. E., Townsend, K. L., Cypess, A. M., Mishina, Y. M., Gussoni, E., & Tseng, Y. (2013) · Nature · doi:10.1038/nature11943 · Cited by 389
Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders
Lehr, S., Hartwig, S., & Sell, H. (2011) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201100052 · Cited by 376
Ravussin, É., Smith, S. R., Mitchell, J. A., Shringarpure, R., Shan, K., Maier, H., Koda, J. E., & Weyer, C. (2009) · Obesity · doi:10.1038/oby.2009.184 · Cited by 335
Severely Impaired Adipsin Expression in Genetic and Acquired Obesity
Flier, J. S., Cook, K. S., Usher, P., & Spiegelman, B. M. (1987) · Science · doi:10.1126/science.3299706 · Cited by 329
Kuba, K., Zhang, L., Imai, Y., Arab, S., Chen, M., Maekawa, Y., Leschnik, M. W., Leibbrandt, A., Markovic, M., Schwaighofer, J., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.158659 · Cited by 316
Nauck, M. A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.002 · Cited by 298
Castan‐Laurell, I., Dray, C., Attané, C., Duparc, T., Knauf, C., & Valet, P. (2011) · Endocrine · doi:10.1007/s12020-011-9507-9 · Cited by 297
Adipokines – removing road blocks to obesity and diabetes therapy
Blüher, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.005 · Cited by 273
Self-citationIncretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
Drucker, D. J. (2013) · Diabetes · doi:10.2337/db13-0822 · Cited by 272
Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
Moon, H., Dalamaga, Μ., Kim, S. Y., Pοlyzos, S. A., Hamnvik, O. R., Magkos, F., Paruthi, J., & Mantzoros, C. S. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1053 · Cited by 265
Dalmas, É., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron‐Wisnewsky, J., Lacroix‐Desmazes, S., Bayry, J., Kaveri, S. V., Clément, K., et al. (2014) · Diabetes · doi:10.2337/db13-1511 · Cited by 256
Adiponectin, driver or passenger on the road to insulin sensitivity?
Ye, R., & Scherer, P. E. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.04.001 · Cited by 251
Identification and Validation of Novel Adipokines Released from Primary Human Adipocytes
Lehr, S., Hartwig, S., Lamers, D., Famulla, S., Müller, S., Hanisch, F., Cuvelier, C. A., Ruige, J. B., Eckardt, K., Ouwens, D. M., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010504 · Cited by 249
Number and size of adipose tissue fat cells in relation to metabolism in human obesity
Björntorp, P. A., & Sjöström, L. (1971) · Metabolism · doi:10.1016/0026-0495(71)90084-9 · Cited by 243
Chakaroun, R., Raschpichler, M., Klöting, N., Oberbach, A., Flehmig, G., Kern, M., Schön, M. R., Shang, E., Lohmann, T., Dreßler, M., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.10.008 · Cited by 234
Self-citationAdipokines in gestational diabetes
Fasshauer, M., Blüher, M., & Stumvoll, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70176-1 · Cited by 230
Self-citationWeekly Subcutaneous Pegylated Recombinant Native Human Leptin (PEG-OB) Administration in Obese Men
Hukshorn, C. J., Saris, W. H. M., Westerterp-Plantenga, M. S., Farid, A. R., Smith, F. J., & Campfield, L. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6955 · Cited by 220
Adipose Dipeptidyl Peptidase-4 and Obesity
Sell, H., Blüher, M., Klöting, N., Schlich, R., Willems, M., Ruppe, F., Knoefel, W. T., Dietrich, A., Fielding, B. A., Arner, P., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0496 · Cited by 219
Self-citationBMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis
Gustafson, B., Hammarstedt, A., Hedjazifar, S., Hoffmann, J. M., Svensson, P., Grimsby, J. S., Rondinone, C. M., & Smith, U. (2015) · Diabetes · doi:10.2337/db14-1127 · Cited by 219
Gao, D., Madi, M., Ding, C., Fok, M., Steele, T., Ford, C. T., Hunter, L., & Chen, B. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2013 · Cited by 216
Winzell, M. S., Magnusson, C., & Åhrén, B. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.05.004 · Cited by 212
The role of adipokines in β-cell failure of type 2 diabetes
Dunmore, S., & Brown, J. E. P. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0278 · Cited by 212
Clinical Relevance of Adipokines
Blüher, M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.5.317 · Cited by 210
Self-citationDalamaga, Μ., Chou, S. H.-H., Shields, K. S., Papageorgiou, P., Pοlyzos, S. A., & Mantzoros, C. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.010 · Cited by 199
Inflammation links excess fat to insulin resistance: the role of the interleukin‐1 family
Tack, C. J., Stienstra, R., Joosten, L. A. B., & Netea, M. G. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01145.x · Cited by 199
Inventing new medicines: The FGF21 story
Kharitonenkov, A., & Adams, A. C. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.12.003 · Cited by 198
FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases
Itoh, N. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00107 · Cited by 198
Vaspin in obesity and diabetes: pathophysiological and clinical significance
Blüher, M. (2011) · Endocrine · doi:10.1007/s12020-011-9572-0 · Cited by 195
Self-citationApelin Decreases Lipolysis via Gq, Gi, and AMPK-Dependent Mechanisms
Yue, P., Jin, H. H., Xu, S., Aillaud, M., Deng, A. C., Azuma, J., Kundu, R. K., Reaven, G. M., Quertermous, T., & Tsao, P. S. (2010) · Endocrinology · doi:10.1210/en.2010-0576 · Cited by 171
Youn, B., Bang, S. I., Klöting, N., Park, J. W., Lee, N., Oh, J.-E., Pi, K., Lee, T. H., Ruschke, K., Faßhauer, M., et al. (2008) · Diabetes · doi:10.2337/db08-1147 · Cited by 171
Self-citationVaccaro, A. R., Whang, P. G., Patel, T. C., Phillips, F. M., Anderson, D. G., Albert, T. J., Hilibrand, A. S., Brower, R. S., Kurd, M. F., Appannagari, A., et al. (2007) · The Spine Journal · doi:10.1016/j.spinee.2007.03.012 · Cited by 169
Vaspin inhibits kallikrein 7 by serpin mechanism
Heiker, J. T., Klöting, N., Kovacs, P. L., Kuettner, E. B., Sträter, N., Schultz, S., Kern, M., Stümvoll, M., Blüher, M., & Beck‐Sickinger, A. G. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1258-8 · Cited by 166
Self-citationRegulation of Lipolysis in Small and Large Fat Cells of the Same Subject
Laurencikiene, J., Skurk, T., Kulyté, A., Hedén, P., Åström, G., Sjölin, E., Rydén, M., Hauner, H., & Arner, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1702 · Cited by 164
Klöting, N., Kovacs, P. L., Kern, M., Heiker, J. T., Faßhauer, M., Schön, M. R., Stümvoll, M., Beck‐Sickinger, A. G., & Blüher, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2137-1 · Cited by 160
Self-citationAdiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration
Okamoto, M., Ohara‐Imaizumi, M., Kubota, N., Hashimoto, S., Eto, K., Kanno, T., Kubota, T., Wakui, M., Nagai, R., Noda, M., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0944-9 · Cited by 156
Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism
Schulz, T. J., & Tseng, Y.-H. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.019 · Cited by 154
Gustafson, B., & Smith, U. (2012) · Diabetes · doi:10.2337/db11-1419 · Cited by 147
Röhrborn, D., Eckel, J., & Sell, H. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.08.029 · Cited by 141
Flehmig, G., Scholz, M. R., Klöting, N., Faßhauer, M., Tönjes, A., Stümvoll, M., Youn, B., & Blüher, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099785 · Cited by 140
Self-citationCotillard, A., Poitou, C., Torcivia, A., Bouillot, J., Dietrich, A., Klöting, N., Grégoire, C., Lolmède, K., Blüher, M., & Clément, K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1074 · Cited by 139
Self-citationThe genetics of fat distribution
Schleinitz, D., Böttcher, Y., Blüher, M., & Kovacs, P. (2014) · Diabetologia · doi:10.1007/s00125-014-3214-z · Cited by 134
Self-citationKrist, J., Wieder, K., Klöting, N., Oberbach, A., Kralisch, S., Wiesner, T., Schön, M. R., Gärtner, D., Dietrich, A., Shang, E., et al. (2013) · Obesity Facts · doi:10.1159/000348667 · Cited by 124
Self-citationLee, E. S., Park, S., Kim, E., Yoon, Y. S., Ahn, H. Y., Park, C., Yun, Y. H., & Oh, S. W. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt087 · Cited by 121
LeRoith, D., Novosyadlyy, R., Gallagher, E. J., Lann, D. E., Vijayakumar, A., & Yakar, S. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1081488 · Cited by 120
Functional annotation of the human fat cell secretome
Dahlman, I. A., Elsen, M., Tennagels, N., Korn, M., Brockmann, B., Sell, H., Eckel, J., & Arner, P. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.685745 · Cited by 107
Wascher, T. C., Lindeman, J. H. N., Sourij, H., Kooistra, T., Pacini, G., & Roden, M. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00221 · Cited by 105
Townsend, K. L., Suzuki, R., Huang, T. L., Jing, E., Schulz, T. J., Lee, K., Taniguchi, C. M., Espinoza, D. O., McDougall, L. E., Zhang, H., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-199067 · Cited by 105
Wu, Z., Cheng, Y., Gu, W., & Aung, L. H. H. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.001 · Cited by 103
Liang, H., Yin, B., Zhang, H., Zhang, S., Zeng, Q., Wang, J., Jiang, X., Li, Y., Wang, C., & Li, Z. (2008) · Endocrinology · doi:10.1210/en.2007-0978 · Cited by 94
Serum FGF-21 Levels in Type 2 Diabetic Patients
Cheng, X., Zhu, B. L., Jiang, F., & Fan, H. (2011) · Endocrine Research · doi:10.3109/07435800.2011.558550 · Cited by 73
Zhang, Y., Zitsman, J. L., Hou, J., Fennoy, I., Guo, K., Feinberg, J. B., & Leibel, R. L. (2013) · Obesity · doi:10.1002/oby.20528 · Cited by 60
Adiponectin and its receptors: implications for obesity-associated diseases and longevity
Kadowaki, T., Yamauchi, T., Okada‐Iwabu, M., & Iwabu, M. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70120-7 · Cited by 47
Karas, M. G., Benkeser, D. C., Arnold, A. M., Bartz, T. M., Djoussé, L., Mukamal, K. J., Ix, J. H., Zieman, S. J., Siscovick, D. S., Tracy, R. P., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.027 · Cited by 45
Cao, J., Li, H., & Chen, L. (2014) · Current Drug Targets · doi:10.2174/1389450115666141128120053 · Cited by 45
Côté, M., Cartier, A., Reuwer, A. Q., Arsenault, B. J., Lemieux, I., Després, J., Wareham, N. J., Kastelein, J. J. P., Boekholdt, S. M., & Khaw, K. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.053 · Cited by 40
Hmamouchi, I., Roux, C., Paternotte, S., Kolta, S., Dougados, M., & Briot, K. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.131150 · Cited by 37
Importance of adipokines in glucose homeostasis
Blüher, M. (2013) · Diabetes Management · doi:10.2217/dmt.13.35 · Cited by 26
Self-citationRegulation of dipeptidyl peptidase 4 production in adipocytes by glucose
Hirasawa, N., Das, S., Hayashi, H., Sato, T., Yamada, R., & Hiratsuka, M. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s62610 · Cited by 20
Foo, J., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.04.013 · Cited by 17
Flagged first, then by citations
1 of the 104 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
Segerstolpe, Å., Palasantza, A., Eliasson, P., Andersson, E.-M., Andréasson, A.-C., Sun, X., Picelli, S., Sabirsh, A., Clausen, M., Bjursell, M. K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.020 · Cited by 1,550
Obesity in adults: a clinical practice guideline
Wharton, S., Lau, D. C. W., Vallis, M., Sharma, A. M., Biertho, L., Campbell-Scherer, D., Adamo, K., Alberga, A., Bell, R., Boulé, N., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.191707 · Cited by 1,506
Adipogenesis and metabolic health
Ghaben, A. L., & Scherer, P. E. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0093-z · Cited by 1,395
Stem cell-based therapy for human diseases
Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T. L., Nguyen, Q. T., Phan, T. T. K., Nguyen, G. H., Le, P. T. T., Hoang, V. T., Forsyth, N. R., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01134-4 · Cited by 1,074
Animal models of obesity and diabetes mellitus
Kleinert, M., Clemmensen, C., Hofmann, S. M., Moore, M. C., Renner, S., Woods, S. C., Huypens, P., Beckers, J., de Angelis, M. H., Schürmann, A., et al. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.161 · Cited by 893
Metadata
- Authors
- Fasshauer, M., & Blüher, M.
- Affiliations
- Leipzig University (DE)
- Corresponding author
- Blüher, Matthias
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 36
- Issue
- 7
- Pages
- 461-470
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W1513674275
- Cited by
- 1,050
- References
- 104
- Citations by year
- 2026: 55 · 2025: 82 · 2024: 94 · 2023: 142 · 2022: 141 · 2021: 114 · 2020: 105 · 2019: 88 · 2018: 84 · 2017: 63 · 2016: 59 · 2015: 20
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- adipokines, obesity, adipose tissue dysfunction, leptin, adiponectin, FGF21, retinol-binding protein 4, dipeptidyl peptidase IV, bone morphogenetic proteins, vaspin, apelin, progranulin, obesity-related comorbidities, metabolic disorders, cardiovascular disease, chronic inflammation, cancer, pharmacotherapy, diagnostic biomarkers
- MeSH terms
- Adipose Tissue, Animals, Diabetes Mellitus, Type 2, Humans, Obesity, Biomarkers, Adipokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review